Workflow
威高血净：拟对威高泰尔茂增资0.725亿元
Shandong Weigao Blood Purification ProductsShandong Weigao Blood Purification Products(SH:603014) Ge Long Hui·2025-11-20 09:08

Core Viewpoint - Weigao Blood Purification (603014.SH) announced a capital increase to support the development of its peritoneal dialysis fluid business through a joint investment with Taimao (China) Investment Co., Ltd. [1] Group 1 - The company plans to increase its capital by 72.5 million RMB [1]